Cargando…

Vismodegib dose reduction effective when combined with itraconazole for the treatment of advanced basal cell carcinoma

Detalles Bibliográficos
Autor principal:	Yoon, Jaeyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750706/ https://www.ncbi.nlm.nih.gov/pubmed/33364281 http://dx.doi.org/10.1016/j.jdcr.2020.11.014

Ejemplares similares

Intracranial regression of an advanced basal cell carcinoma using sonidegib and itraconazole after failure with vismodegib
por: Yoon, Jaeyoung, et al.
Publicado: (2017)

Treatment of periocular basal cell carcinoma with neoadjuvant vismodegib
por: Su, Maxwell G., et al.
Publicado: (2020)

Rapid response to vismodegib in a patient with advanced basal cell carcinoma
por: Vornicova, Olga, et al.
Publicado: (2015)

Vismodegib and orbital excision for treating locally advanced basal cell carcinoma
por: Hogarty, Daniel T, et al.
Publicado: (2018)

Combination Trimodality Therapy Using Vismodegib for Basal Cell Carcinoma of the Face
por: Block, Alec M., et al.
Publicado: (2015)

Treatment of Locally Advanced Basal Cell Carcinomas with Vismodegib
por: Mastronardi, Luis, et al.
Publicado: (2021)

Basal cell carcinoma: multimodal treatment and the role of neoadjuvant vismodegib
por: Martins, Pedro Carvalho, et al.
Publicado: (2019)

Complete pathologic clearance with vismodegib in advanced basal cell carcinoma of the scalp with cranial invasion
por: Dodson, Joseph, et al.
Publicado: (2022)

Vismodegib in Locally Advanced Basal Cell Carcinoma in Slovenia
por: Mesti, Tanja, et al.
Publicado: (2022)

Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma
por: Macha, Muzafar A, et al.
Publicado: (2013)

Vismodegib: A smoothened inhibitor for the treatment of advanced basal cell carcinoma
por: Aditya, Suruchi, et al.
Publicado: (2013)

Vismodegib treatment in advanced basal cell carcinomas: Real‐life experience
por: Villani, Alessia, et al.
Publicado: (2021)

Targeted Therapy for Advanced Basal-Cell Carcinoma: Vismodegib and Beyond
por: Cowey, C. Lance
Publicado: (2013)

Giant morphea-form basal cell carcinoma of the umbilicus: Successful debulking with vismodegib
por: Orduz Robledo, Mariana, et al.
Publicado: (2018)

Vismodegib-resistant basal cell carcinomas in basal cell nevus syndrome: Clinical approach and genetic analysis
por: Sinx, Kelly A.E., et al.
Publicado: (2018)

Upfront Radiotherapy with Concurrent and Adjuvant Vismodegib Is Effective and Well-Tolerated in a Patient with Advanced, Multifocal Basal Cell Carcinoma
por: Franco, Abigail I., et al.
Publicado: (2018)

Vismodegib: the Proof of Concept in Basal Cell Carcinoma
por: Berrada, Narjiss, et al.
Publicado: (2014)

Benefit–risk assessment of sonidegib and vismodegib in the treatment of locally advanced basal cell carcinoma
por: García Ruiz, Antonio J, et al.
Publicado: (2022)

Vismodegib for giant, locally advanced, basal cell carcinoma and its complex position in clinical practice
por: Koekelkoren, Fabiënne H.J., et al.
Publicado: (2019)

Inhibition of CAL27 Oral Squamous Carcinoma Cell by Targeting Hedgehog Pathway With Vismodegib or Itraconazole
por: Freitas, Raíza Dias, et al.
Publicado: (2020)

Metastatic same-site squamous cell carcinoma arising during vismodegib therapy for basal cell carcinoma
por: Zhao, Raymond, et al.
Publicado: (2022)

Reflectance Confocal Microscopy Identification of Subclinical Basal Cell Carcinoma after Vismodegib Treatment: Report of a Case
por: Villani, Alessia, et al.
Publicado: (2021)

Characterization of intractable diarrhea resulting from vismodegib treatment for basal cell nevus syndrome
por: Patel, Ashmi, et al.
Publicado: (2022)

Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study): Neoadjuvant Vismodegib in Locally Advanced Basal Cell Carcinoma
por: Bertrand, Nicolas, et al.
Publicado: (2021)

Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome
por: Weiss, Glen J., et al.
Publicado: (2011)

Pilomatricomas secondary to treatment with vismodegib
por: Magdaleno-Tapial, Jorge, et al.
Publicado: (2018)

Granulation tissue masquerading as basal cell carcinoma after treatment with vismodegib
por: Miedema, Jayson, et al.
Publicado: (2017)

Gene-Related Response of Basal Cell Carcinoma to Biologic Treatment with Vismodegib
por: Sternfeld, Amir, et al.
Publicado: (2020)

Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma
por: Chang, Anne Lynn S., et al.
Publicado: (2016)

A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell Carcinoma
por: Odom, Dawn, et al.
Publicado: (2017)

Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma
por: Yurchenko, Andrey A., et al.
Publicado: (2022)

Non-surgical Management of Locally Advanced Basal Cell Carcinoma of the Upper Extremity With Vismodegib
por: Swisher, Austin R, et al.
Publicado: (2022)

Investigational agents in metastatic basal cell carcinoma: focus on vismodegib
por: Batty, Nicolas, et al.
Publicado: (2012)

Vismodegib: First-in-Class Hedgehog Pathway Inhibitor for Metastatic or Locally Advanced Basal Cell Carcinoma
por: Nix, Nancy M., et al.
Publicado: (2014)

Vismodegib for Preservation of Visual Function in Patients with Advanced Periocular Basal Cell Carcinoma: The VISORB Trial
por: Kahana, Alon, et al.
Publicado: (2021)

Tolerance of sonidegib after intolerance of vismodegib—Experience in two patients with nevoid basal cell carcinoma syndrome (Gorlin syndrome)
por: Venturi, Federico, et al.
Publicado: (2023)

18-FDG PET/CT assessment of basal cell carcinoma with vismodegib
por: Thacker, Curtis A, et al.
Publicado: (2012)

Female Patient with Two Simultaneous Giants Facial Basal Cell Carcinomas Demonstrates a Positive Response to Vismodegib as a Monotherapy
por: Theotokoglou, Sofia, et al.
Publicado: (2021)

Analysis of efficacy and safety of vismodegib therapy in patients with advanced basal cell carcinoma – real world multicenter cohort study
por: Słowińska, M., et al.
Publicado: (2022)

Key Clinical Adverse Events in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib or Vismodegib: A Post Hoc Analysis
por: Gutzmer, Ralf, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hgvujvvr2vvoukjceh1m4ks4i6